The FDA cleared the way for what is hoped may be a more affordable version of the popular arthritis drug Enbrel. Tuesday the agency approved Erelzi (etanercept-szzs), a "biosimilar" to Enbrel.
From: http://redirect.viglink.com?u=http%3A%2F%2Fwww.webmd.com%2Frheumatoid-arthritis%2Fnews%2F20160901%2Ferelzi-biosimilar-enbrel-arthritis-faq%3Fsrc%3DRSS_PUBLIC&key=ddaed8f51db7bb1330a6f6de768a69b8
No comments:
Post a Comment